Spinal bone density in women using depot medroxyprogesterone contraception

Obstetrics and Gynecology

Volumn 92, Issue 4, 1998, Pages 569-573

  Cundy, Tim ^a   Cornish, Jill ^a   Roberts, Helen ^a   Elder, Hinemoa ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; AGE; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MASS; CALCIUM INTAKE; CONTRACEPTION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; SPINE;

EID: 0031685950     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(98)00270-1     Document Type: Article

References (14)

1. Jeppsson S, Gershagen S, Johansson EDB, Rannevik G. Plasma levels of medroxyprogesterone acetate (MPA), sex hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long term use of depot-MPA as a contraceptive agent. Acta Endocrinol 1982;99:339-43
2. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1991;303:13-6
3. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosig- nani PG. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol 1996;175:396-401
4. Cundy T, Cornish J, Evans MC, Gamble G, Stapleton J, Reid IR. Sources of interracial variation in bone mineral density. J Bone Miner Res 1995;10:368-73
5. Angus RM, Sambrook PN, Pocock NA, Eisman JA. A simple method of assessing calcium intake in Caucasian women. J Am Diet Assoc 1989;89:209-14
6. Wilson PWF, Paffenbarger RS, Morris JN, Havlik RJ. Assessment methods for physical activity and physical fitness in population studies. Am Heart J 1986;111:1177-92
7. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9
8. Lindsay R, Cosman F, Herrington BS, Himmelstein S. Bone mass and body composition in normal women. J Bone Miner Res 1992;7:55-63
9. Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ 1994;308:247-8
10. Cundy T, Farquhar CM, Cornish J, Reid IR. Short term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women. J Clin Endocrinol Metab 1996;81:1014-7
11. Westhoff C. Depot medroxyprogesterone acetate contraception: metabolic parameters and mood changes. J Reprod Med 1996;41 Suppl 5:401-6
12. Hooper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994;330:387-92
13. Michnovicz JJ, Hershcopf RJ, Nagamuna H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogen effect of cigarette smoking. N Engl J Med 1986;315:1305-9
14. Cromer BA, Blair JM, Mahon JD, Zibners L, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo Provera), levonorg- estrel (Norplant) or oral contraceptives. J Pediatr 1996;129:671-6